Container closure integrity testing (CCIT) is used to evaluate whether a pharmaceutical or medical device package can maintain its integrity throughout its intended lifecycle. Pharmaceutical package testing can provide data on the ability of a package to prevent the ingress or egress of gases, liquids, microorganisms, or other contaminants.
However, establishing an in-house CCIT program can require specialized equipment, trained personnel, method development, validated procedures, and ongoing maintenance. For companies that do not perform CCIT testing frequently or require specialized testing capabilities, outsourcing can provide access to technical expertise and laboratory infrastructure without building a complete internal testing program. But selecting a CCIT testing partner involves more than finding a laboratory that can perform a leak test. Companies need to consider testing methods, package configurations, sensitivity requirements, regulatory expectations, reporting, sample handling, and the partner's experience with similar applications.
So, what should companies look for when outsourcing CCIT?
Why Companies Choose to Outsource CCIT?
Pharmaceutical, biotechnology, medical device, and other manufacturers may outsource container closure integrity testing for several reasons:
- Access to Specialized Equipment
External testing laboratories can provide access to technologies such as vacuum decay, pressure decay, helium leak detection, high-voltage leak detection, force decay, and airborne ultrasound. This allows manufacturers to select methods suited to their package and testing requirements without investing in multiple systems.
Experienced CCIT partners can support method selection, development, sample preparation, test parameters, controls, acceptance criteria, and data interpretation based on the package, product, and study objectives.
- Reduced Infrastructure Requirements
Outsourcing can reduce the need for in-house investment in specialized equipment, trained personnel, calibration, maintenance, software, environmental controls, and documented procedures, particularly for companies with occasional testing needs.
- Support for Development and Validation
CCIT laboratories can support various stages of the packaging lifecycle, including package development, method feasibility and validation, packaging validation, stability and transportation studies, routine testing, and leak investigations.
Understanding CCIT Outsourcing Requirements
Before selecting a CCIT testing partner, define the requirements based on the package configuration, materials, product characteristics, headspace, leak detection sensitivity, acceptance criteria, and testing conditions.
Different packages, such as vials, pre-filled syringes, pouches, blister packs, bottles, cartridges, and medical device trays, may require different testing methods and fixtures. Package materials and product properties such as viscosity, conductivity, volatility, and temperature sensitivity can also influence method selection. Headspace may affect test feasibility and sensitivity, while the required leak size and acceptance criteria should be established before testing.
Storage and transportation conditions should also be considered, particularly for packages exposed to cold or ultra-cold temperatures. A suitable outsourcing partner should be able to evaluate these factors and recommend a testing approach appropriate for the package and study objectives.
Evaluating Testing Methods and Technical Capabilities
One of the most important considerations when selecting a CCIT outsourcing partner is the range of testing technologies and package integrity test solutions available.
A laboratory offering only one method may not be able to provide the best approach for every package type. Instead, look for a partner capable of evaluating the packaging system and selecting a suitable technique.
1. Vacuum Decay
Vacuum decay is a non-destructive container closure integrity testing method that detects leaks by monitoring changes in vacuum pressure within a test chamber. During the test, the package is placed inside a sealed chamber, and a vacuum is applied around the package. If the package has a leak, air or gas can move through the defect, producing a measurable change in the chamber pressure. The system monitors this pressure change and compares the measured response against predefined acceptance criteria to determine whether the package passes or fails. Vacuum decay can be applied to a wide range of rigid and flexible pharmaceutical and medical device packages, including vials, bottles, pouches, blister packs, trays, and other sealed configurations.
2. Helium Leak Detection
Helium leak detection is a highly sensitive deterministic CCIT method that uses helium as a tracer gas to identify and quantify leaks in sealed packages. In a typical test, the package is filled or charged with helium and then placed under vacuum in a test chamber connected to a helium mass spectrometer. If a leak is present, helium escapes through the leak path and is detected by the instrument. The resulting signal can be used to determine a helium leak rate, providing quantitative information about package integrity rather than simply producing a PASS or FAIL result. Since helium atoms are small and chemically inert, helium can be used to identify very small leak paths when the package and test configuration are appropriately designed. The method can be applied to pharmaceutical and medical device packaging, including vials, syringes, cartridges, and other sealed containers.
3. High-Voltage Leak Detection
High-voltage leak detection (HVLD) is a non-destructive method that identifies defects in electrically conductive product-filled packages by detecting changes in electrical current associated with a leak path. During testing, an electrical potential is applied between electrodes positioned around or near the package. When the package contains a conductive liquid and an opening or defect connects the product to the external environment, the electrical circuit can be completed through the conductive product, resulting in a detectable change in current. The system evaluates this electrical response against predefined criteria to identify potential package defects. MicroCurrent HVLD uses controlled, lower-current inspection and can be applied to suitable liquid-filled pharmaceutical packages, including vials, cartridges, and pre-filled syringes.
These methods may be suitable for specific package formats and should be evaluated based on package design and test objectives.
How Regulatory Compliance Shapes CCIT Testing?
Regulatory expectations influence how container closure integrity testing is selected, performed, documented, and evaluated. For pharmaceutical and medical device manufacturers, the testing approach should align with applicable standards and guidance while addressing the specific packaging system and study objectives. USP <1207> provides guidance on container closure integrity testing for pharmaceutical packaging and discusses deterministic and probabilistic approaches. Deterministic methods such as vacuum decay, helium leak detection, and high-voltage leak detection can provide measurable and reproducible results when appropriately developed and applied.
ASTM and ISO standards can also provide frameworks for specific CCIT applications. ASTM F2338, for example, describes vacuum decay leak testing, while ASTM F2391 addresses helium tracer gas leak testing. For medical device packaging, ISO 11607 provides requirements related to packaging systems for terminally sterilized medical devices. When outsourcing CCIT, manufacturers should verify that the testing partner understands the applicable standards and can select, develop, and validate a method appropriate for the package configuration, product characteristics, and required leak detection sensitivity.
Regulatory considerations also extend to equipment qualification, calibration, test procedures, reference leak standards, sample handling, data integrity, acceptance criteria, and reporting. A qualified testing partner should maintain documented procedures and provide traceable test records that clearly identify the samples, method, test conditions, acceptance criteria, and results. Evaluating these capabilities before outsourcing can help manufacturers obtain reliable CCIT data that supports packaging development, validation, stability studies, and regulatory documentation.
Questions to Ask Before Selecting a CCIT Partner
1. Do you have experience with my package application?
Ask whether the laboratory has previously tested similar vials, syringes, cartridges, pouches, blister packs, trays, bottles, or other packaging configurations.
2. Which CCIT methods do you offer?
A broader technology portfolio can provide more flexibility when determining the appropriate testing approach.
3. How do you select the testing method?
The laboratory should be able to explain how package construction, product characteristics, sensitivity requirements, and study objectives influence method selection.
4. What standards do you follow?
Ask which ASTM standards, USP chapters, ISO standards, and other applicable guidance documents are incorporated into the testing program.
5. How are instruments calibrated?
Understand the laboratory's approach to calibration, leak standards, system checks, preventive maintenance, and equipment qualification.
6. Can you test under specific environmental conditions?
If the packaging will be exposed to temperature extremes, transportation conditions, or other environmental stresses, determine whether the laboratory can accommodate these requirements.
7. How are samples handled?
Sample identification, storage, transportation, conditioning, and chain-of-custody procedures can all affect testing integrity.
8. What is the expected turnaround time?
Testing timelines can affect development schedules, validation activities, and regulatory submissions. Confirm expected lead times before beginning a project.
Conclusion
Outsourcing container closure integrity testing can give pharmaceutical and medical device manufacturers access to specialized equipment, technical expertise, and testing infrastructure without establishing a complete in-house laboratory.
However, the right testing partner should be selected based on more than equipment availability. Companies should evaluate package experience, testing technologies, method development capabilities, achievable sensitivity, regulatory knowledge, validation support, data integrity, reporting, and the ability to handle future testing requirements.
A strong CCIT outsourcing partner should be able to understand the packaging system, identify appropriate testing options, develop or validate methods where required, and provide reliable data that supports packaging development and quality objectives.
Ultimately, successful CCIT outsourcing begins with choosing a partner whose technical capabilities, testing approach, quality systems, and regulatory understanding align with the needs of the packaging system.
center of excellence